Scarica l'app Stockscreener
32.58
0.18%
-0.1103
Precedente Chiudi:
$32.69
Aprire:
$32.87
Volume 24 ore:
166.69K
Relative Volume:
0.33
Capitalizzazione di mercato:
$1.62B
Reddito:
$447.57M
Utile/perdita netta:
$-38.92M
Rapporto P/E:
-39.25
EPS:
-0.83
Flusso di cassa netto:
$-1.15M
1 W Prestazione:
-9.99%
1M Prestazione:
-17.58%
6M Prestazione:
+15.67%
1 anno Prestazione:
-4.00%
Intervallo 1D:
$32.49
$33.69
Intervallo di 1 settimana:
$32.49
$36.15
Portata 52W:
$18.94
$43.11
Atricure Inc Stock (ATRC) Company Profile
Nome
Atricure Inc
Settore
Industria
Telefono
513-755-4100
Indirizzo
7555 INNOVATION WAY, MASON, OH
Confronta ATRC con altri titoli
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
ATRC
Atricure Inc
|
32.55 | 1.62B | 447.57M | -38.92M | -1.15M | -0.83 |
|
ISRG
Intuitive Surgical Inc
|
479.87 | 171.84B | 8.35B | 2.32B | 1.30B | 6.41 |
|
BDX
Becton Dickinson Co
|
224.06 | 64.03B | 20.64B | 1.73B | 2.94B | 6.02 |
|
ALC
Alcon Inc
|
87.35 | 43.91B | 9.91B | 1.02B | 665.00M | 2.05 |
|
RMD
Resmed Inc
|
219.00 | 32.15B | 4.93B | 1.25B | 1.38B | 8.47 |
|
BAX
Baxter International Inc
|
34.74 | 17.46B | 17.28B | 108.00M | 391.00M | 0.20 |
Atricure Inc Stock (ATRC) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2024-12-17 | Ripresa | JP Morgan | Overweight |
| 2024-04-23 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2023-10-23 | Iniziato | JMP Securities | Mkt Outperform |
| 2023-09-29 | Iniziato | UBS | Buy |
| 2021-08-05 | Downgrade | Oppenheimer | Outperform → Perform |
| 2020-12-18 | Reiterato | Needham | Buy |
| 2020-11-06 | Reiterato | Needham | Buy |
| 2020-04-07 | Iniziato | Oppenheimer | Outperform |
| 2020-02-06 | Iniziato | BTIG Research | Buy |
| 2020-01-24 | Reiterato | Needham | Buy |
| 2019-08-13 | Downgrade | Northland Capital | Outperform → Market Perform |
| 2019-04-12 | Iniziato | JP Morgan | Overweight |
| 2018-10-04 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Needham | Buy |
| 2018-08-02 | Reiterato | Stifel | Buy |
| 2018-06-18 | Reiterato | Needham | Buy |
| 2018-04-27 | Reiterato | Needham | Buy |
| 2018-01-16 | Reiterato | Needham | Buy |
| 2017-11-02 | Reiterato | Needham | Buy |
| 2017-07-28 | Reiterato | Needham | Buy |
| 2017-05-30 | Ripresa | Piper Jaffray | Overweight |
| 2016-06-30 | Ripresa | JMP Securities | Mkt Outperform |
| 2015-10-28 | Reiterato | Needham | Buy |
| 2015-10-06 | Reiterato | Canaccord Genuity | Buy |
| 2015-10-06 | Reiterato | Needham | Buy |
Mostra tutto
Atricure Inc Borsa (ATRC) Ultime notizie
AtriCure Investor Day: New Product Pipeline and Financial Targets Coming March 2025 - StockTitan
AtriCure, Inc. to Host Earnings Call - ACCESS Newswire
AtriCure Independent Director Karen Prange Sells 25% Of Holding - Simply Wall St
(ATRC) Long Term Investment Analysis - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Stock Price Down 6% Following Insider Selling - Defense World
Atricure director Karen Prange sells $232,531 in stock By Investing.com - Investing.com Canada
Atricure Director Makes a Significant Stock Sale! - TipRanks
Insider Sell: Karen Prange Sells 6,100 Shares of AtriCure Inc (A - GuruFocus.com
Atricure director Karen Prange sells $232,531 in stock - Investing.com India
Insider Buying: Chief Technical Officer Salvatore Privitera Acqu - GuruFocus.com
Rhumbline Advisers Has $2.41 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - Defense World
AtriCure, Inc. (NASDAQ:ATRC) Q4 2024 Earnings Call Transcript - MSN
26,035 Shares in AtriCure, Inc. (NASDAQ:ATRC) Acquired by AlphaCentric Advisors LLC - MarketBeat
HighMark Wealth Management LLC Has $2.56 Million Holdings in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Short Interest in AtriCure, Inc. (NASDAQ:ATRC) Declines By 20.4% - MarketBeat
Stifel Nicolaus Raises AtriCure (NASDAQ:ATRC) Price Target to $48.00 - MarketBeat
AtriCure (NASDAQ:ATRC) Price Target Raised to $45.00 at Oppenheimer - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Down 5.8%Here's What Happened - MarketBeat
AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Piper Sandler Analyst Says - MarketBeat
Canaccord Genuity Group Forecasts Strong Price Appreciation for AtriCure (NASDAQ:ATRC) Stock - MarketBeat
AtriCure (NASDAQ:ATRC) Announces Earnings Results - MarketBeat
AtriCure (ATRC) Expected to Announce Earnings on Thursday - MarketBeat
AtriCure's (ATRC) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat
AtriCure targets $517M-$527M revenue in 2025 with new product launches and international growth - MSN
Exploring Analyst Estimates for AtriCure (ATRC) Q4 Earnings, Beyond Revenue and EPS - MSN
(ATRC) Technical Pivots with Risk Controls - Stock Traders Daily
AtriCure (NASDAQ:ATRC) Stock Price Expected to Rise, Canaccord Genuity Group Analyst Says - Defense World
AtriCure (NASDAQ:ATRC) Price Target Raised to $51.00 at JPMorgan Chase & Co. - MarketBeat
Atricure Files For Mixed Shelf; Size Not DisclosedSEC Filing -February 14, 2025 at 03:53 pm EST - Marketscreener.com
AtriCure (ATRC) Upgraded to Buy: Here's What You Should Know - MSN
AtriCure Inc. (ATRC) reports earnings - Quartz
AtriCure, Inc. SEC 10-K Report - TradingView
WCM Investment Management LLC Sells 23,785 Shares of AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Silver Oak Securities Incorporated Invests $220,000 in AtriCure, Inc. (NASDAQ:ATRC) - MarketBeat
Earnings call transcript: AtriCure Q4 2024 revenue rises, stock dips By Investing.com - Investing.com Australia
AtriCure’s Earnings Call Highlights Strong Growth and Positive Outlook - TipRanks
AtriCure (NASDAQ:ATRC) Earns Market Outperform Rating from JMP Securities - MarketBeat
AtriCure (ATRC) Reports Q4 Loss, Lags Revenue Estimates - MSN
Earnings call transcript: AtriCure Q4 2024 revenue rises, stock dips - MSN
Atricure Inc Azioni (ATRC) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.95%
0.38%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):